MedPath

Comparison of I-gel airway vs SLIPA 2G airway in paediatric paitents undergoing general anaesthesia with caudal epidural anaesthesia

Not yet recruiting
Registration Number
CTRI/2023/07/055820
Lead Sponsor
yashashvi chouhan
Brief Summary

Supraglottic airway devices are commonly used in general anaesthesia as a less invasive alternative to endotracheal intubation. Use of supraglottic airways have many advantages over endotracheal intubation like more heamodynamic stability, less incidence of post operative sore throat, cough and hoarseness of voice. This study compares the two second generation supraglottic airway devices in peadiatric patient undergoing general anaesthesia with caudal epidural anaesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 1ASA physical status I and II.
  • 2Age between 1 to 12 years.
  • 3Patients undergoing elective surgeries like hernia repair, hypospdiasis repair, Circumcision and brief procedures like cystoscopy under general anesthesia with caudal epidural anaesthesia.
  • 4Patients giving consent.
Exclusion Criteria

1operation time expected >4 hours 2 risk of aspiration, 3 known difficult airway 4congenital malformations involving respiratory tract 5cervical spine disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare ease of insertion and oropharyngeal seal pressure in two second generation supraglottic airway devices, I-gel and SLIPA-2G0MIN, 1MIN,2MIN,3MIN,4MIN,5MIN
Secondary Outcome Measures
NameTimeMethod
To assess pharyngolaryngeal morbidity as hoarseness of voice in post anaesthesia care unit.0MIN,1MIN,2MIN,3MIN,4MIN,5MIN

Trial Locations

Locations (1)

KLE Dr Prabhakar Kore hospital belgaum

🇮🇳

Belgaum, KARNATAKA, India

KLE Dr Prabhakar Kore hospital belgaum
🇮🇳Belgaum, KARNATAKA, India
YASHASHVI CHOUHAN
Principal investigator
8554845030
yashashvichouhan7@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.